WO2007017895A3 - Compositions pharmaceutiques stabilisees de cephalosporines - Google Patents

Compositions pharmaceutiques stabilisees de cephalosporines Download PDF

Info

Publication number
WO2007017895A3
WO2007017895A3 PCT/IN2006/000160 IN2006000160W WO2007017895A3 WO 2007017895 A3 WO2007017895 A3 WO 2007017895A3 IN 2006000160 W IN2006000160 W IN 2006000160W WO 2007017895 A3 WO2007017895 A3 WO 2007017895A3
Authority
WO
WIPO (PCT)
Prior art keywords
cephalosporin
oral pharmaceutical
stability
pharmaceutical compositions
pharmaceutical composition
Prior art date
Application number
PCT/IN2006/000160
Other languages
English (en)
Other versions
WO2007017895A2 (fr
Inventor
Himadri Sen
Makarand Avachat
Sanjay Wagh
Bharat Metkar
Abhijit Dhamne
Original Assignee
Lupin Ltd
Himadri Sen
Makarand Avachat
Sanjay Wagh
Bharat Metkar
Abhijit Dhamne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd, Himadri Sen, Makarand Avachat, Sanjay Wagh, Bharat Metkar, Abhijit Dhamne filed Critical Lupin Ltd
Priority to JP2008509579A priority Critical patent/JP2008540403A/ja
Priority to EP06809918A priority patent/EP1883393A2/fr
Publication of WO2007017895A2 publication Critical patent/WO2007017895A2/fr
Publication of WO2007017895A3 publication Critical patent/WO2007017895A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques orales de céphalosporines, et notamment du cefpodoxime, un procédé pour leur préparation et un procédé destiné à renforcer la stabilité de ces compositions pharmaceutiques orales. La composition pharmaceutique orale d'une céphalosporine est stable et présente une biodisponibilité adéquate, et comprend une céphalosporine ainsi que de l'amidon de maïs. Le procédé de préparation d'une composition pharmaceutique orale d'une céphalosporine consiste à réduire la taille de la céphalosporine et à la mélanger avec de l'amidon de maïs et un ou plusieurs excipients. Le procédé destiné à renforcer le profil de stabilité d'une céphalosporine dans une composition pharmaceutique consiste à mettre la céphalosporine en contact avec une dose renforçant la stabilité d'amidon de maïs présentant une teneur en humidité inférieure ou égale à 2 %. La suspension orale présente un profil de stabilité amélioré par comparaison avec une composition pharmaceutique en suspension orale comprenant ladite céphalosporine mais ne contenant pas d'amidon de maïs en dose renforçant la stabilité.
PCT/IN2006/000160 2005-05-05 2006-05-05 Compositions pharmaceutiques stabilisees de cephalosporines WO2007017895A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2008509579A JP2008540403A (ja) 2005-05-05 2006-05-05 セファロスポリンの安定化経口用医薬組成物
EP06809918A EP1883393A2 (fr) 2005-05-05 2006-05-05 Compositions pharmaceutiques stabilisees de cephalosporines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN556/MUM/2005 2005-05-05
IN556MU2005 2005-05-05

Publications (2)

Publication Number Publication Date
WO2007017895A2 WO2007017895A2 (fr) 2007-02-15
WO2007017895A3 true WO2007017895A3 (fr) 2007-04-19

Family

ID=37672426

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000160 WO2007017895A2 (fr) 2005-05-05 2006-05-05 Compositions pharmaceutiques stabilisees de cephalosporines

Country Status (3)

Country Link
EP (1) EP1883393A2 (fr)
JP (1) JP2008540403A (fr)
WO (1) WO2007017895A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201007107A1 (tr) * 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları.
TR201007106A1 (tr) * 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Sefpodoksim proksetil formülasyonları.
TR201009167A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefalosporin içeren farmasötik granüller.
TR201009168A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Suda dağılan sefpodoksim proksetil formülasyonları.
JP2013147488A (ja) * 2011-12-21 2013-08-01 Taisho Pharmaceutical Co Ltd 固形製剤
JP6449873B2 (ja) * 2013-07-18 2019-01-09 サンド・アクチエンゲゼルシヤフト 抗生物質のドライシロップ製剤用の粉末混合物
CN103479589B (zh) * 2013-09-22 2016-04-13 海南葫芦娃制药有限公司 头孢泊肟酯分散片及其制备方法
WO2017046756A1 (fr) * 2015-09-18 2017-03-23 Lupin Limited Esters de céfixime proxétil et axétil

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132583A (en) * 1964-12-16 1968-11-06 Glaxo Lab Ltd Pharmaceutical compositions containing cephalosporins
US3931404A (en) * 1972-12-06 1976-01-06 Hoechst Aktiengesellschaft High dosage orally administrable cephalosporin antibiotic preparations
US3945994A (en) * 1973-02-08 1976-03-23 Gist-Brocades N.V. Novel acid compounds
WO2002067943A1 (fr) * 2001-02-27 2002-09-06 Ranbaxy Laboratories Limited Composition pharmaceutique orale de cefpodoxime-proxetil
WO2004022727A1 (fr) * 2002-09-06 2004-03-18 Vri Biomedical Ltd Bacterie probiotique : lactobacillus fermentum

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132583A (en) * 1964-12-16 1968-11-06 Glaxo Lab Ltd Pharmaceutical compositions containing cephalosporins
US3931404A (en) * 1972-12-06 1976-01-06 Hoechst Aktiengesellschaft High dosage orally administrable cephalosporin antibiotic preparations
US3945994A (en) * 1973-02-08 1976-03-23 Gist-Brocades N.V. Novel acid compounds
WO2002067943A1 (fr) * 2001-02-27 2002-09-06 Ranbaxy Laboratories Limited Composition pharmaceutique orale de cefpodoxime-proxetil
WO2004022727A1 (fr) * 2002-09-06 2004-03-18 Vri Biomedical Ltd Bacterie probiotique : lactobacillus fermentum

Also Published As

Publication number Publication date
JP2008540403A (ja) 2008-11-20
WO2007017895A2 (fr) 2007-02-15
EP1883393A2 (fr) 2008-02-06

Similar Documents

Publication Publication Date Title
WO2007017895A3 (fr) Compositions pharmaceutiques stabilisees de cephalosporines
MXPA05010562A (es) Composicion en polvo de proteinas.
WO2007127665A3 (fr) Nouvelles formulations stabilisant et inhibant la précipitation de compositions immunogènes
EA018193B3 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
EP1338210B8 (fr) Agent stabilisant de protéines
WO2007090610A3 (fr) COMPOSITIONS CONTENANT DU ß-CAROTENE
EP2219616A4 (fr) Composition pharmaceutique lyophilisée à stabilité améliorée contenant des dérivés de taxane, et procédé de préparation correspondant
DK1897558T3 (da) Fast præparat af 2-hexadecyloxy-6-methyl-4h-3,1-benzoxazin-4-on
WO2006028996A3 (fr) Microspheres d'emulsan-alginate et procedes d'utilisation de celles-ci
WO2008042836A3 (fr) Compositions à base de beurre de noix et procédés associés
CA2411918A1 (fr) Compositions cristallines liquides cubiques et procedes de production
WO2008039472A3 (fr) Compositions stabilisatrices pour antibiotiques et leurs méthodes d'utilisation
IL145991A0 (en) Food composition with high solids content, a method for its preparation as well as the use of carrageenans for gelling a food composition
RU2009120217A (ru) Малонабухающий крахмал
WO2007087350A3 (fr) Méthodes de régulation de la gélification de solutions de polysaccharides et leurs utilisations
WO2004078105A3 (fr) Composition de fondaparinux sodique de haute purete
WO2005079759A3 (fr) Composition pharmaceutique pour administration per os et mode de fabrication
UA95088C2 (ru) Композиция, которая содержит наночастички связанные с биосовместимым полимером противоракового агента и снижает аллопецию при химиотерапии, способ ее получения
TNSN07012A1 (en) A process for the preparation of a piroxicam : beta-cyclodextrin inclusion compound
WO2003063824A3 (fr) Composition pharmaceutique
ATE344848T1 (de) Wässrige zusammensetzung und deren verwendung zur papierherstellung
WO2008067436A3 (fr) Composés et formulations appropriés pour une désactivation de radicaux
TW200640933A (en) Anthelmintic compounds
WO2004073686A3 (fr) Solutions de medicaments dans du menthol
WO2005006860A3 (fr) Derives d'azole et procedes de fabrication associes

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2008509579

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2006809918

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2006809918

Country of ref document: EP